Ignite Creation Date:
2025-12-24 @ 12:37 PM
Ignite Modification Date:
2026-02-26 @ 6:53 AM
Study NCT ID:
NCT03728361
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-18
First Post:
2018-10-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer
Sponsor:
Dwight Owen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-31
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2018-10-29
First Submit QC Date:
None
Study First Post Date:
2018-11-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-17
Last Update Post Date:
2025-12-18
Last Update Post Date Type:
ESTIMATED